UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
First lung disease reported here with suspected ties to vaping
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo
|
2019-10-14 18:01
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon
|
2019-10-11 16:35
라인
‘Direct-to-consumer genetic testing needs preparation’
The government has decided to deregulate direct-to-consumer (DTC) genetic t...
by Kim Eun-young
|
2019-10-11 15:12
라인
Korea to serve as WHO's executive country
The Ministry of Health and Welfare said that Korea would serve as a member ...
by Lee Han-soo
|
2019-10-10 11:31
라인
Korea, Latin America speed up expanding cooperation in healthcare
The Ministry of Health and Welfare plans to expand cooperation between Kore...
by Lee Han-soo
|
2019-10-08 18:04
라인
Korea, Peru compare notes on telemedicine
Government and industry officials from Korea and Peru gathered for the 5th ...
by Lee Han-soo
|
2019-10-08 15:20
라인
Propofol abuse, addiction increasing at alarming rate
A Ministry of Food and Drug Safety report has shown that more than 160,000 ...
by Lee Han-soo
|
2019-10-07 17:56
라인
Civic group protests regulator’s inaction over insulin pumps FDA recalled
A civic group supporting diabetic patients said it would hold a rally to pr...
by Lee Hye-seon
|
2019-10-07 16:10
라인
Regulator under fire for neglecting reported side effects of Invossa
The Ministry of Food and Drug Safety has come under criticism for doing lit...
by Lee Han-soo
|
2019-10-04 14:59
라인
Foreign patients visiting Korea rise by 17.8% in 2018
The number of foreigners getting medical treatment in Korea increased last ...
by Lee Han-soo
|
2019-10-02 17:50
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon
|
2019-10-02 14:51
라인
Regulator raids cell therapy makers too often to little avail
In the wake of the recall of cell gene therapy Invossa-K, the Ministry of F...
by Jeong Sae-im
|
2019-10-02 11:23
라인
Cost of smartphone-related illness tops ₩400 billion in 2018
Medical expenses to treat smartphone-related diseases such as dry eye syndr...
by Lee Han-soo
|
2019-10-01 15:47
라인
Will parliamentary audit uncover why Invossa was mislabeled?
The National Assembly’s Health and Welfare Committee is expected to focus o...
by Jeong Sae-im
|
2019-10-01 15:45
라인
Drug regulator under fire for going too far, too late
The Ministry of Food and Drug Safety (MFDS)'s ability and credibility a...
by Lee Han-soo
|
2019-09-27 17:48
라인
Foreign trainees satisfied with Lee Jong-wook Fellowship
The Lee Jong-wook Fellowship is receiving favorable feedback from trainees ...
by Choi Gwang-seok
|
2019-09-27 15:05
라인
Regulator explained why it banned stomach medicine ranitidine altogether
The Ministry of Food and Drug Safety Thursday offered a briefing to pharmac...
by Jeong Sae-im
|
2019-09-27 15:02
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon
|
2019-09-26 13:32
라인
Korea, Uzbekistan speed up public health cooperation
Korea will accelerate cooperation with Uzbekistan in public health, initiat...
by Kwak Sung-sun
|
2019-09-25 15:26
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon
|
2019-09-25 14:46
-
이전
21
22
23
24
25
26
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top